DE1288448U - - Google Patents

Info

Publication number
DE1288448U
DE1288448U DENDAT1288448D DE1288448DU DE1288448U DE 1288448 U DE1288448 U DE 1288448U DE NDAT1288448 D DENDAT1288448 D DE NDAT1288448D DE 1288448D U DE1288448D U DE 1288448DU DE 1288448 U DE1288448 U DE 1288448U
Authority
DE
Germany
Prior art keywords
dea
der
uen
over
lat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1288448D
Other languages
German (de)
English (en)
Publication of DE1288448U publication Critical patent/DE1288448U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
DENDAT1288448D Active DE1288448U (OSRAM)

Publications (1)

Publication Number Publication Date
DE1288448U true DE1288448U (OSRAM)

Family

ID=608238

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1288448D Active DE1288448U (OSRAM)

Country Status (1)

Country Link
DE (1) DE1288448U (OSRAM)

Similar Documents

Publication Publication Date Title
Marichev et al. Recent advances in the synthesis, structural diversity, and applications of mesoionic 1, 2, 3-triazol-5-ylidene metal complexes
Bock et al. Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints
Gad Drug safety evaluation
Mancini et al. 2022 Canadian Cardiovascular Society guideline for use of GLP-1 receptor agonists and SGLT2 inhibitors for cardiorenal risk reduction in adults
Portoghese From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes
Williams et al. The role of the dorsal vagal complex and the vagus nerve in feeding effects of melanocortin-3/4 receptor stimulation
DE1288448U (OSRAM)
Kumar et al. Foldamer scaffolds suggest distinct structures are associated with alternative gains-of-function in a preamyloid toxin
Min et al. A Comprehensive Review on the Pharmacokinetics and Drug− Drug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist
Fraser et al. Pharmacological demarcation of the growth hormone, gut motility and feeding effects of ghrelin using a novel ghrelin receptor agonist
CN103065058A (zh) 一种传统药物毒性评价方法及其系统
Rendell Albiglutide for the management of type 2 diabetes
Sun et al. Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity
Conn et al. Pharmacoperone”: What’s in a word
Abernathy et al. The statistical and pharmacological sensitivity of nonclinical QTc analysis comparing jacketed telemetry and multilead snapshot recording in the same dogs
Trompeter et al. Impact of obtaining medications from pharmaceutical company assistance programs on therapeutic goals
Chen et al. Synthetic nucleic acids from thymidine and organotin dihalides and their ability to inhibit human cancer cell lines including pancreatic acid and glioblastomas cell lines
Vezzani Top EU R&D investors in the global economy. Benchmarking technological capabilities in the health industry
Parson The art of reading sequence electropherograms
Silvestre-Roig Prof. Dr. Carlos Silvestre-Roig
Medley et al. Genomic evolution of epitopes and Low Complexity Regions in Plasmodium
Allen ARTICLES & ESSAYS
Sales American
Schade et al. The Basis of Atherosclerotic Guidelines—Time for a Change?
Blumenthal The APHA Medical Care Section Proposal for a National Health Plan